Epidermolysis bullosa acquisita induced by atezolizumab

J Dtsch Dermatol Ges. 2023 Nov;21(11):1407-1409. doi: 10.1111/ddg.15203. Epub 2023 Sep 1.

Authors

Elena Carmona-Rocha¹, María Aguado², Carla Tubau¹, Sofía Sánchez², Anna Mozos³, Ivana Sullivan^#², Jorge Spertino^#¹

Affiliations

¹ Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
² Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
³ Anatomical Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

^# Contributed equally.

PMID: 37658659
DOI: 10.1111/ddg.15203

No abstract available

Keywords: anti-PD-L1; atezolizumab; bullous dermatosis; epidermolysis bullosa acquisita; immune-related adverse events; immunotherapy.

Publication types

Letter